Search
Rugonersen
go.drugbank.com/drugs/DB18662InvestigationalRugonersen is a locked nucleic acid antisense oligonucleotide under investigation for the treatment of Angelman Syndrome.
INCB-086550
go.drugbank.com/drugs/DB18901InvestigationalINCB-086550 is under investigation in clinical trial NCT04629339 (Study of INCB086550 in Select Solid Tumors).
Leflutrozole
go.drugbank.com/drugs/DB19047InvestigationalLeflutrozole is under investigation in clinical trial NCT02908074 (A 6 Month Safety Extension Study of MBGS205).
Ligustrazine
go.drugbank.com/drugs/DB19074InvestigationalLigustrazine is under investigation in clinical trial NCT05942352 (Clinical Study of Ligustrazine in Treating Alcohol Addiction).
REM-422
go.drugbank.com/drugs/DB19304InvestigationalREM-422 is an orally bioavailable, small molecule mRNA degrader of the proto-oncogene c-Myb.
Rocatinlimab
go.drugbank.com/drugs/DB18809InvestigationalRocatinlimab is a subcutaneously administered anti-OX40 antibody developed for the treatment of moderate-to-severe atopic dermatitis. … Additionally, the diverse genetic backgrounds of patients may influence the drug’s effectiveness and side effects.[A263823]
Creatinine
go.drugbank.com/drugs/DB11846InvestigationalCreatinine has been used in trials studying the treatment of Amyotrophic Lateral Sclerosis.
Cadazolid
go.drugbank.com/drugs/DB11847InvestigationalCadazolid has been used in trials studying the treatment of Clostridium Difficile Infection.
Avagacestat
go.drugbank.com/drugs/DB11893InvestigationalAvagacestat has been investigated for the basic science and treatment of Alzheimer Disease.
Decoglurant
go.drugbank.com/drugs/DB11923InvestigationalDecoglurant has been used in trials studying the treatment of Major Depressive Disorder.